Next-Generation Erythropoiesis-Stimulating Agents Drive Market Evolution
The rising burden of chronic diseases is increasing the need for supportive treatment options across healthcare systems. Erythropoietin drugs are contributing to the management of selected anemia conditions associated with long-term illnesses. Market Overview The Erythropoietin Drug Market was valued at US$ 13.14 billion in 2025 and is projected to reach US$ 29.00 billion by 2034, registering a...
0 Comentários 0 Compartilhamentos 5 Visualizações 0 Anterior